| D2 | 'Stable patients' need health services too: HIV-related symptoms are common amongst people eligible for less-intensive differentiated service delivery treatment models in Harare, Zimbabwe | E-poster | Impact evaluation of differentiated service delivery |
| D2 | Scaling up the community eMTCT delivery system during COVID-19 pandemic lock down in Uganda - a case of TASO Gulu, Northern Uganda | E-poster | Impact evaluation of differentiated service delivery |
| D2 | The effectiveness of community-based multi-month dispensing of antiretroviral treatment with single annual clinical visits for newly stable HIV patients: a pooled analysis of two cluster-randomized trials in Southern Africa | E-poster | Impact evaluation of differentiated service delivery |
| D2 | Differentiated HIV care for people using second-line antiretroviral therapy in South Africa: a retrospective cohort study | E-poster | Impact evaluation of differentiated service delivery |
| D2 | Scale-up of multi-month dispensation of antiretroviral therapy among children living with HIV as a COVID-19 mitigation measure and retention strategy, Zambia, 2020 | E-poster | Impact evaluation of differentiated service delivery |
| D2 | An evaluation of nurse-led Community ART Distribution (CAD) for stable ART clients in Malawi | E-poster | Impact evaluation of differentiated service delivery |
| D2 | Impact of a family-centered care model on viral suppression among HIV-infected children in Migori, Kenya | E-poster | Impact evaluation of differentiated service delivery |
| D2 | Clinical outcomes of community ART distribution: DRC's experience with the PODI+ model | E-poster | Impact evaluation of differentiated service delivery |
| D2 | Cost-effectiveness of community delivery of HIV care in South Africa | E-poster | Impact evaluation of differentiated service delivery |
| D2 | Does onsite HIV self-testing enhance linkage to care? A case study of HIVST Challenge Fund Project in Kenya | E-poster | Impact evaluation of differentiated service delivery |